Literature DB >> 19508374

Herpes simplex virus infection downmodulates NKG2D ligand expression.

D Schepis1, M D'Amato, M Studahl, T Bergström, K Kärre, L Berg.   

Abstract

Herpes simplex virus (HSV) type 1 infection may cause orofacial infections in humans. The virus resides in a latent form in neural ganglia and occasionally reactivates and infects epithelial cells. Natural killer (NK) cells have been implicated in immune control of herpes virus infections, possibly by downmodulating major histocompatibility complex (MHC) class I and by other, as yet unidentified, mechanisms. Upon HSV-1 infection of cell lines, surface levels of NKG2D ligands MHC class I related proteins (MIC) A and UL16 binding protein 2 were downmodulated due to late viral gene product(s). As also MHC class I levels were reduced by HSV-1, NK cell recognition of HeLa cells was not affected by infection. Total cellular MICA contents remained unchanged, suggesting masking, internalization or intracellular retention of MICA as possible mechanisms of viral downregualtion of MICA surface levels. Furthermore, NK cells from patients with active HSV-1 infection had a tendency towards increased expression level of the activating receptor NKG2D. These data support a role for NKG2D-MICA interactions in immune responses to HSV-1 reactivation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508374     DOI: 10.1111/j.1365-3083.2009.02241.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  24 in total

1.  Reduced degranulation of NK cells in patients with frequently recurring herpes.

Authors:  Vladimir V Murugin; Irina N Zuikova; Nina E Murugina; Andrey E Shulzhenko; Boris V Pinegin; Mikhail V Pashenkov
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

2.  Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.

Authors:  Tessa M Campbell; Brian P McSharry; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 3.  NKG2D ligands as therapeutic targets.

Authors:  Paul Spear; Ming-Ru Wu; Marie-Louise Sentman; Charles L Sentman
Journal:  Cancer Immun       Date:  2013-05-01

Review 4.  Here today--not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections.

Authors:  Seung-Hwan Lee; Christine A Biron
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

5.  Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells.

Authors:  Korneel Grauwet; Claudia Cantoni; Monica Parodi; Andrea De Maria; Bert Devriendt; Daniela Pende; Lorenzo Moretta; Massimo Vitale; Herman W Favoreel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-28       Impact factor: 11.205

6.  NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d.

Authors:  Carlotta Kuylenstierna; Niklas K Björkström; Sofia K Andersson; Peter Sahlström; Lidija Bosnjak; Dominic Paquin-Proulx; Karl-Johan Malmberg; Hans-Gustaf Ljunggren; Markus Moll; Johan K Sandberg
Journal:  Eur J Immunol       Date:  2011-06-06       Impact factor: 5.532

Review 7.  Herpesvirus Evasion of Natural Killer Cells.

Authors:  Steffi De Pelsmaeker; Nicolas Romero; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

8.  Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections.

Authors:  Karin Vogel; Sabrina Thomann; Benjamin Vogel; Philipp Schuster; Barbara Schmidt
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

9.  Crystal structure of the cowpox virus-encoded NKG2D ligand OMCP.

Authors:  Eric Lazear; Lance W Peterson; Chris A Nelson; Daved H Fremont
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

10.  Pseudorabies Virus US3 Protein Kinase Protects Infected Cells from NK Cell-Mediated Lysis via Increased Binding of the Inhibitory NK Cell Receptor CD300a.

Authors:  K Grauwet; M Vitale; S De Pelsmaeker; T Jacob; K Laval; L Moretta; M Parodi; S Parolini; C Cantoni; H W Favoreel
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.